Henry Schein | HSIC - Operating Expenses

Stock Price
72.51
Daily Change
-0.10 -0.14%
Monthly
-6.09%
Yearly
0.64%
Q2 Forecast
69.35

Henry Schein reported $3.17B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Align Technology USD 862.03M 39.18M Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cigna USD 42.21B 497.12M Mar/2026
Concord Medical Services Hldg CNY 345.26M 153.27M Jun/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
CVS Health USD 95.75B 7.84B Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Encompass Health USD 1.27B 6.3M Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Laboratory Of America USD 3.13B 6.3M Mar/2026
McKesson USD 94.46B 10.04B Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Owens Minor USD -464.76M 1.17B Mar/2026
Quest Diagnostics USD 2.5B 76M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tenet Healthcare USD 4.81B 156M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Universal Health Services USD 3.99B 23.51M Mar/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 1.12B 457.15M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026